Solventum(SOLV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SOLV Solventum

Post-Mkt 02-27 17:00:49 EST

74.20

-2.74

-3.56%

盘后75.40

+1.20+1.62%

16:54 EST

High77.89	Low73.00	Vol2.24M
Open73.00	D1 Closing76.94	Amplitude6.36%
Mkt Cap12.87B	Tradable Cap10.94B	Total Shares173.45M
T/O166.65M	T/O Rate1.52%	Tradable Shares147.51M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SOLV","market":"US","secType":"STK","nameCN":"Solventum","latestPrice":74.2,"timestamp":1772226000000,"preClose":76.94,"halted":0,"volume":2241840,"hourTrading":{"tag":"盘后","latestPrice":75.4,"preClose":74.2,"latestTime":"16:54 EST","volume":109820,"amount":8148639.6072,"timestamp":1772229286300,"change":1.2,"changeRate":0.016173,"amplitude":0.016307},"delay":0,"changeRate":-0.035612165323628736,"floatShares":147505438,"shares":173447557,"eps":8.719205,"marketStatus":"Post-Mkt","change":-2.74,"latestTime":"02-27 17:00:49 EST","open":73,"high":77.89,"low":73,"amount":166649933.8632,"amplitude":0.063556,"askPrice":75.67,"askSize":26,"bidPrice":72.86,"bidSize":60,"shortable":3,"etf":0,"ttmEps":8.719205,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772240400000},"marketStatusCode":4,"adr":0,"listingDate":1711944000000,"exchange":"NYSE","adjPreClose":76.94,"preHourTrading":{"tag":"盘前","latestPrice":72.8,"preClose":76.94,"latestTime":"09:13 EST","volume":199629,"amount":15359449.271130001,"timestamp":1772201601356,"change":-4.14,"changeRate":-0.053808,"amplitude":0.053808},"postHourTrading":{"tag":"盘后","latestPrice":75.4,"preClose":74.2,"latestTime":"16:54 EST","volume":109820,"amount":8148639.6072,"timestamp":1772229286300,"change":1.2,"changeRate":0.016173,"amplitude":0.016307},"volumeRatio":1.863257,"impliedVol":0.3503,"impliedVolPercentile":0.6454},"requestUrl":"/m/hq/s/SOLV/tweets","defaultTab":"tweets","newsList":[{"id":"2614410865","title":"Solventum Corporation (SOLV) Receives a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2614410865","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614410865?lang=en_us&edition=fundamental","pubTime":"2026-02-28 01:08","pubTimestamp":1772212121,"startTime":"0","endTime":"0","summary":"In a report released today, Rick Wise from Stifel Nicolaus maintained a Buy rating on Solventum Corporation, with a price target of $105.00. Wise c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/solventum-corporation-solv-receives-a-buy-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/solventum-corporation-solv-receives-a-buy-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","BK4198","SOLV","BK4127"],"gpt_icon":0},{"id":"1152968319","title":"Stock Track | Solventum Plummets 5.12% Intraday Despite Beating Earnings Estimates on Margin Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1152968319","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152968319?lang=en_us&edition=fundamental","pubTime":"2026-02-27 22:32","pubTimestamp":1772202764,"startTime":"0","endTime":"0","summary":"Solventum's stock plummeted 5.12% at the market open on Friday, marking a significant downward move for the healthcare supplier.The decline came despite the company reporting strong fourth-quarter...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["SOLV"],"gpt_icon":0},{"id":"2614594058","title":"Solventum Is Maintained at Overweight by Keybanc","url":"https://stock-news.laohu8.com/highlight/detail?id=2614594058","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614594058?lang=en_us&edition=fundamental","pubTime":"2026-02-27 21:44","pubTimestamp":1772199840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SOLV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 27, 2026 08:44 ET (13:44 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOLV"],"gpt_icon":0},{"id":"2614561428","title":"Solventum price target raised to $99 from $97 at KeyBanc","url":"https://stock-news.laohu8.com/highlight/detail?id=2614561428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614561428?lang=en_us&edition=fundamental","pubTime":"2026-02-27 21:19","pubTimestamp":1772198346,"startTime":"0","endTime":"0","summary":"KeyBanc raised the firm’s price target on Solventum (SOLV) to $99 from $97 and keeps an Overweight rating on the shares following quarterly results...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/solventum-price-target-raised-to-99-from-97-at-keybanc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/solventum-price-target-raised-to-99-from-97-at-keybanc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOLV"],"gpt_icon":0},{"id":"2614185636","title":"Solventum Beat Wall Street Earnings Estimates. The Stock Is Down. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2614185636","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614185636?lang=en_us&edition=fundamental","pubTime":"2026-02-27 21:12","pubTimestamp":1772197920,"startTime":"0","endTime":"0","summary":"Shares of healthcare supplier Solventum fell early Friday after the company offered strong fourth-quarter earnings and 2026 guidance.Solventum stock was down 5.4% in premarket trading at $72.81, making it the worst-performing stock in early trading. S&P 500 and Dow Jones Industrial Average futures were down 0.6% and 0.7%, respectively.The move came after the maker of surgical wound care and oral car products reported adjusted earnings per share of $1.57 on Thursday evening, up from $1.41 a year ago. Sales were $2 billion, up 3.5% year over year on a comparable basis.Wall Street was looking for earnings per share of $1.49 from sales of $2 billion. Fourth-quarter results don't seem to be the problem.Surgical sales were $1.2 billion in the quarter, up 5.2% year over year. Dental solution sales were $343 million, up 8.6% year over year.For 2026, Solventum expects adjusted earnings per share of $6.40 to $6.60. Wall Street currently projects earnings per share of $6.44. Guidance doesn't look","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOLV"],"gpt_icon":0},{"id":"2614830214","title":"Wells Fargo Adjusts Price Target on Solventum to $83 From $86, Maintains Equalweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2614830214","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614830214?lang=en_us&edition=fundamental","pubTime":"2026-02-27 19:59","pubTimestamp":1772193575,"startTime":"0","endTime":"0","summary":"Solventum (SOLV) has an average rating of overweight and mean price target of $91.64, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SOLV"],"gpt_icon":0},{"id":"2614883415","title":"Solventum Price Target Maintained With a $100.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2614883415","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614883415?lang=en_us&edition=fundamental","pubTime":"2026-02-27 18:40","pubTimestamp":1772188800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SOLV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 27, 2026 05:40 ET (10:40 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOLV"],"gpt_icon":0},{"id":"2614839122","title":"Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY), Solventum Corporation (SOLV) and Privia Health Group (PRVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614839122","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614839122?lang=en_us&edition=fundamental","pubTime":"2026-02-27 17:51","pubTimestamp":1772185888,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on DENTSPLY SIRONA (XRAY – Research Report), Solventum Corporation (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dentsply-sirona-xray-solventum-corporation-solv-and-privia-health-group-prva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dentsply-sirona-xray-solventum-corporation-solv-and-privia-health-group-prva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4137","LABU","LU0128526141.USD","PRVA","BK4581","XLV","BK4196","LU0029874061.USD","BK4539","SOLV","BK4198","XRAY","XBI","HCSG","BK4588"],"gpt_icon":0},{"id":"2614388089","title":"U.S. RESEARCH ROUNDUP-Cars.Com, Dell, Zscaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2614388089","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614388089?lang=en_us&edition=fundamental","pubTime":"2026-02-27 16:20","pubTimestamp":1772180449,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Cars.Com, Dell, ZscalerFeb 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cars.Com, Dell Techn","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nL4N3ZN0ON:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHDN","DLLL","XYZG","MNST","LU0124676726.USD","DELL","ADSK","BLD","VSEC","WD","SHAK","AAOI","ZS","DT","CHE","CARS","CRWG","IONS","SNOU","ARRY","INTU","GDRX","OII","SNOY","XYZ","SBAC","ROOT","CRWU","CWVX","ORA","TFX","RYTM","IBP","AMPH","FOUR","CRWV","TKO","CRWD","FTDR","SOLV","PZZA","SJM","MIDD","CORD","CABO","SNOW","MLM","XYZY","CRWL","CAI"],"gpt_icon":0},{"id":"2614388507","title":"Solventum Corp : Jefferies Raises Target Price to $84 From $75","url":"https://stock-news.laohu8.com/highlight/detail?id=2614388507","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614388507?lang=en_us&edition=fundamental","pubTime":"2026-02-27 14:11","pubTimestamp":1772172689,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZN0EZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","SOLV"],"gpt_icon":0},{"id":"2614071065","title":"Solventum Q4 sales beat estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2614071065","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614071065?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:52","pubTimestamp":1772142776,"startTime":"0","endTime":"0","summary":"Solventum Q4 sales beat estimatesOverviewHealthcare solutions provider's Q4 sales beat analyst expectationsAdjusted EPS for Q4 beat analyst expectationsOutlookSolventum expects full-year 2026 organic ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nL1N3ZM1HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","SOLV"],"gpt_icon":0},{"id":"2614716030","title":"Solventum beats quarterly estimates on strong demand for surgical products","url":"https://stock-news.laohu8.com/highlight/detail?id=2614716030","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614716030?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:41","pubTimestamp":1772142102,"startTime":"0","endTime":"0","summary":"Solventum beats quarterly estimates on strong demand for surgical products Feb 26 (Reuters) - Medical device maker Solventum SOLV.N on Thursday beat Wall Street estimates for the fourth quarter, helpe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nL4N3ZM2FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","SOLV"],"gpt_icon":0},{"id":"2614486071","title":"GUIDANCE: (SOLV) Solventum Expects 2026 Adjusted EPS Range $6.40-$6.60, vs. FactSet Est of $6.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2614486071","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614486071?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:34","pubTimestamp":1772141699,"startTime":"0","endTime":"0","summary":"GUIDANCE: (SOLV) Solventum Expects 2026 Adjusted EPS Range $6.40-$6.60, vs. FactSet Est of $6.34","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SOLV"],"gpt_icon":0},{"id":"2614076485","title":"Solventum Q4 Adj. EPS $1.57 Beats $1.50 Estimate, Sales $1.998B Beat $1.962B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2614076485","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614076485?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:13","pubTimestamp":1772140435,"startTime":"0","endTime":"0","summary":"Solventum (NYSE:SOLV) reported quarterly earnings of $1.57 per share which beat the analyst consensus estimate of $1.50 by 4.95 percent. This is a 11.35 percent increase over earnings of $1.41 per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50910258/solventum-q4-adj-eps-1-57-beats-1-50-estimate-sales-1-998b-beat-1-962b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Solventum Q4 Adj. EPS $1.57 Beats $1.50 Estimate, Sales $1.998B Beat $1.962B Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOLV"],"gpt_icon":0},{"id":"2614079987","title":"Solventum reports Q4 adjusted EPS $1.57, consensus $1.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2614079987","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614079987?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:10","pubTimestamp":1772140220,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $2B, consensus $1.96B. “Solventum’s (SOLV) fourth quarter results reflect another quarter of solid performance resulting in full...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/solventum-reports-q4-adjusted-eps-1-57-consensus-1-50-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/solventum-reports-q4-adjusted-eps-1-57-consensus-1-50-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOLV"],"gpt_icon":0},{"id":"2614907658","title":"Solventum Q4 net income rises 2.1x to USD 63 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614907658","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614907658?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:09","pubTimestamp":1772140162,"startTime":"0","endTime":"0","summary":"Solventum reported Q4 FY2025 net sales of USD 2.0 billion, down 3.7% on a reported basis, with organic sales up 3.5%. GAAP diluted EPS was USD 0.36 and adjusted diluted EPS was USD 1.57. Q4 operating cash flow was USD 96 million and free cash flow was USD 33 million. For FY2025, Solventum posted net sales of USD 8.3 billion, up 0.9%, with net income of USD 1.6 billion  and GAAP diluted EPS of USD 8.88 ; adjusted diluted EPS was USD 6.11, down 8.8%. FY2025 operating cash flow was USD 369 million and free cash flow was no free cash flow, versus USD 805 million a year earlier. In Q4, organic sales growth was driven by Infection Prevention and Surgical Solutions within MedSurg as well as Dental Solutions. The company said debt paydown following the September 2025 sale of its Purification and Filtration business was the primary driver of the increase in adjusted EPS, while adjusted results also reflected operating expense savings and tariff headwinds. Solventum introduced FY2026 guidance fo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL7LGPTJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOLV","BK4198"],"gpt_icon":0},{"id":"2614757870","title":"BRIEF-Solventum Q4 Adjusted EPS USD 1.57 Vs. IBES Estimate USD 1.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2614757870","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614757870?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:05","pubTimestamp":1772139946,"startTime":"0","endTime":"0","summary":"BRIEF-Solventum Q4 Adjusted EPS USD 1.57 Vs. IBES Estimate USD 1.5\n\n\nFeb 26 (Reuters) - Solventum Q4 net income USD 63 million.\n\nQ4 EPS USD 0.36\nQ4 sales USD 1,998 million vs. IBES estimate USD 1,962 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nPLX1689C2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","SOLV"],"gpt_icon":0},{"id":"2614607526","title":"Solventum Outlook FY Organic Sales Growth 2-3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614607526","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614607526?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:05","pubTimestamp":1772139902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nPLX1689C2:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","SOLV"],"gpt_icon":0},{"id":"2614840024","title":"Thermo Fisher FY 2025 GAAP diluted EPS hits USD 17.74, up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614840024","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614840024?lang=en_us&edition=fundamental","pubTime":"2026-02-27 01:13","pubTimestamp":1772125987,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDLbdrGkp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4585","LU0957791311.USD","LU0266013472.USD","LU1989771016.USD","LU1791710400.SGD","LU1815333072.USD","LU2211815571.USD","LU2360108059.USD","LU0234572021.USD","LU0316494557.USD","LU1670628061.USD","LU2112291526.USD","LU1057294990.SGD","LU0208291251.USD","LU2041044095.USD","IE00B19Z8W00.USD","LU0011850046.USD","LU1712237335.SGD","LU0061474960.USD","LU1064131342.USD","LU1623119135.USD","LU2543165471.USD","LU0528227936.USD","LU1791710582.SGD","LU0114720955.EUR","LU1633808545.USD","LU1923622614.USD","LU2125910179.SGD","LU1923622291.USD","LU2298321311.HKD","LU1983299246.USD","BK4533","LU2063271972.USD","LU1720051108.HKD","GB00BDT5M118.USD","LU2720916845.USD","LU2211814178.USD","LU0823416689.USD","LU0640476718.USD","LU2764263039.SGD","LU1670627923.USD","LU1988902786.USD","SOLV","BK4121","LU2764263203.CNY","LU2125909916.SGD","IE00B19Z9505.USD","TMO","LU1854103824.USD"],"gpt_icon":0},{"id":"2614675726","title":"Solventum Corp. Stock Rises Tuesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2614675726","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614675726?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:17","pubTimestamp":1771971420,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Solventum Corp.  rose 1.06% to $73.42 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.77% to 6,890.07 and the Dow Jones Industrial Average  rising 0.76% to 49,174.50.The stock's rise snapped a three-day losing streak.Solventum Corp. closed 16.76% short of its 52-week high of $88.20, which the company reached on December 2nd.Trading volume  remained 236,380 below its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled February 24, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOLV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.solventum.com","stockEarnings":[{"period":"1week","weight":0.0452},{"period":"1month","weight":-0.0086},{"period":"3month","weight":-0.0976},{"period":"6month","weight":0.0527},{"period":"1year","weight":-0.0845},{"period":"ytd","weight":-0.029}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":-0.0089},{"period":"3month","weight":0.0086},{"period":"6month","weight":0.0686},{"period":"1year","weight":0.1594},{"period":"ytd","weight":0.0108}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NYSE","name":"Solventum","nameEN":"Solventum"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Solventum(SOLV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Solventum(SOLV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Solventum,SOLV,Solventum股票,Solventum股票老虎,Solventum股票老虎国际,Solventum行情,Solventum股票行情,Solventum股价,Solventum股市,Solventum股票价格,Solventum股票交易,Solventum股票购买,Solventum股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Solventum(SOLV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Solventum(SOLV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}